Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ray

Showing results (221-230 of 229) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 229 results.
Gynecologie, Obstetrique, Fertilite & Senologie|January 29, 2019
[Part I drafted from the short text of the French Guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Diagnosis management, surgery, perioperative care, and pathological analysis)]V Lavoué, C Huchon, C Akladios, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†C A Bellera, N Penel, M Ouali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2024
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent diseaseJ A Ledermann, X Matias-Guiu, F Amant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2019
Surgery in reference centers improves survival of sarcoma patients: a nationwide studyJ-Y Blay, C Honoré, E Stoeckle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2019
Surgery in reference centers improves survival of sarcoma patients: a nationwide studyJ-Y Blay, C Honoré, E Stoeckle, et al.
ESMO Open|January 30, 2021
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancerP Heudel, S Chabaud, D Perol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2026
ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumoursK S Saini, M Koopman, D Martins-Branco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2024
Improved nationwide survival of sarcoma patients with a network of reference centersJ Y Blay, N Penel, T Valentin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Pageof 23

Showing results (221-230 of 229) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
Gynecologie, Obstetrique, Fertilite & Senologie|January 29, 2019
[Part I drafted from the short text of the French Guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Diagnosis management, surgery, perioperative care, and pathological analysis)]V Lavoué, C Huchon, C Akladios, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†C A Bellera, N Penel, M Ouali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2024
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent diseaseJ A Ledermann, X Matias-Guiu, F Amant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2019
Surgery in reference centers improves survival of sarcoma patients: a nationwide studyJ-Y Blay, C Honoré, E Stoeckle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2019
Surgery in reference centers improves survival of sarcoma patients: a nationwide studyJ-Y Blay, C Honoré, E Stoeckle, et al.
ESMO Open|January 30, 2021
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancerP Heudel, S Chabaud, D Perol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2026
ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumoursK S Saini, M Koopman, D Martins-Branco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2024
Improved nationwide survival of sarcoma patients with a network of reference centersJ Y Blay, N Penel, T Valentin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Pageof 23